Tourmaline Bio, Inc. (TRML)
47.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Tourmaline Bio Shareholders Equity (Quarterly): 259.19M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 44.33B |
| Merck & Co., Inc. | 51.85B |
| UnitedHealth Group, Inc. | 95.79B |
| Gilead Sciences, Inc. | 21.54B |
| Eli Lilly & Co. | 23.79B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 269.30M |
| Total Liabilities (Quarterly) | 10.10M |
| Debt to Equity Ratio | 0.0006 |
| Current Ratio | 24.68 |
| Net Debt Paydown Yield | 0.01% |